These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23842639)

  • 1. The Women's Health Initiative: Hormone Therapy and Calcium/Vitamin D supplementation trials.
    Cauley JA
    Curr Osteoporos Rep; 2013 Sep; 11(3):171-8. PubMed ID: 23842639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
    Manson JE; Crandall CJ; Rossouw JE; Chlebowski RT; Anderson GL; Stefanick ML; Aragaki AK; Cauley JA; Wells GL; LaCroix AZ; Thomson CA; Neuhouser ML; Van Horn L; Kooperberg C; Howard BV; Tinker LF; Wactawski-Wende J; Shumaker SA; Prentice RL
    JAMA; 2024 May; 331(20):1748-1760. PubMed ID: 38691368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of hormone therapy and calcium plus vitamin D for reduction of bone loss and risk for fractures: lessons learned from the Women's Health Initiative.
    Jackson RD; Shidham S
    Curr Osteoporos Rep; 2007 Dec; 5(4):153-9. PubMed ID: 18430389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.
    Control Clin Trials; 1998 Feb; 19(1):61-109. PubMed ID: 9492970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the annual costs of postmenopausal prevention therapy: raloxifene, alendronate, or estrogen-progestin therapy.
    Mullins CD; Ohsfeldt RL
    J Manag Care Pharm; 2003; 9(2):150-8. PubMed ID: 14613344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy.
    Robbins JA; Aragaki A; Crandall CJ; Manson JE; Carbone L; Jackson R; Lewis CE; Johnson KC; Sarto G; Stefanick ML; Wactawski-Wende J
    Menopause; 2014 Feb; 21(2):116-23. PubMed ID: 23799356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of vitamin D in relation to bone health.
    Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
    Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials.
    Sullivan SD; Lehman A; Nathan NK; Thomson CA; Howard BV
    Menopause; 2017 Apr; 24(4):371-378. PubMed ID: 27801706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
    Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
    JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium plus vitamin D supplementation has limited effects on femoral geometric strength in older postmenopausal women: the Women's Health Initiative.
    Jackson RD; Wright NC; Beck TJ; Sherrill D; Cauley JA; Lewis CE; LaCroix AZ; LeBoff MS; Going S; Bassford T; Chen Z
    Calcif Tissue Int; 2011 Mar; 88(3):198-208. PubMed ID: 21253715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis.
    Bolland MJ; Grey A; Avenell A; Gamble GD; Reid IR
    BMJ; 2011 Apr; 342():d2040. PubMed ID: 21505219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set.
    Bolland MJ; Grey A; Gamble GD; Reid IR
    Am J Clin Nutr; 2011 Oct; 94(4):1144-9. PubMed ID: 21880848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium plus vitamin D supplementation and the risk of fractures.
    Jackson RD; LaCroix AZ; Gass M; Wallace RB; Robbins J; Lewis CE; Bassford T; Beresford SA; Black HR; Blanchette P; Bonds DE; Brunner RL; Brzyski RG; Caan B; Cauley JA; Chlebowski RT; Cummings SR; Granek I; Hays J; Heiss G; Hendrix SL; Howard BV; Hsia J; Hubbell FA; Johnson KC; Judd H; Kotchen JM; Kuller LH; Langer RD; Lasser NL; Limacher MC; Ludlam S; Manson JE; Margolis KL; McGowan J; Ockene JK; O'Sullivan MJ; Phillips L; Prentice RL; Sarto GE; Stefanick ML; Van Horn L; Wactawski-Wende J; Whitlock E; Anderson GL; Assaf AR; Barad D;
    N Engl J Med; 2006 Feb; 354(7):669-83. PubMed ID: 16481635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.
    Prentice RL; Pettinger MB; Jackson RD; Wactawski-Wende J; Lacroix AZ; Anderson GL; Chlebowski RT; Manson JE; Van Horn L; Vitolins MZ; Datta M; LeBlanc ES; Cauley JA; Rossouw JE
    Osteoporos Int; 2013 Feb; 24(2):567-80. PubMed ID: 23208074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium supplementation and fracture risk--recent findings from the women's health initiative study.
    Kruse H
    S D Med; 2006 May; 59(5):207-8. PubMed ID: 16729654
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.
    Schnatz PF; Jiang X; Aragaki AK; Nudy M; O'Sullivan DM; Williams M; LeBlanc ES; Martin LW; Manson JE; Shikany JM; Johnson KC; Stefanick ML; Payne ME; Cauley JA; Howard BV; Robbins J
    Obstet Gynecol; 2017 Jan; 129(1):121-129. PubMed ID: 27926633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    Weaver CM; Alexander DD; Boushey CJ; Dawson-Hughes B; Lappe JM; LeBoff MS; Liu S; Looker AC; Wallace TC; Wang DD
    Osteoporos Int; 2016 Jan; 27(1):367-76. PubMed ID: 26510847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative.
    Jackson RD; Mysiw WJ
    Semin Reprod Med; 2014 Nov; 32(6):454-62. PubMed ID: 25321423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
    Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Kooperberg C; Stefanick ML; Jackson RD; Beresford SA; Howard BV; Johnson KC; Kotchen JM; Ockene J;
    JAMA; 2002 Jul; 288(3):321-33. PubMed ID: 12117397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.